For peptic ulcer and gastroesophageal reflux disease
Launch of PPI [Bepzol tablets]
KyungDong Pharm Co., Ltd. launched [Befzol Tablets], a PPI series used for peptic ulcers and gastroesophageal reflux disease, in November. Best Friend Jeong Eun
This product contains Rabeprazole as its main ingredient and is used for peptic ulcers and GERD. Bad eating habits and lifestyle habits
In case of excessive gastric acid secretion due to stress, etc., it is necessary to suppress gastric acid secretion by inhibiting the proton pump.
Befzol tablets have a rapid gastric acid secretion effect and are metabolized non-enzymatically, so drug interactions are very minimal when used in combination with other medications.
It is a product with special features.
It is expected to be of great help in managing digestive diseases along with KyungDong Pharm Co.'s peptic ulcer treatment.
♤ Product Information ♤
1. Product name: Bepzole Tab.
2. Ingredient content: Rabeprazole sodium 10mg/20mg per tablet (Rabeprazole sodium 10mg/20mg)
3. Effectiveness: Gastric ulcer, duodenal ulcer
Erosive or ulcerative gastroesophageal reflux disease
Alleviating symptoms of gastroesophageal reflux disease
Long-term maintenance treatment for esophageal reflux disease
Antibiotic combination therapy for patients with pylori-infected digestive ulcers
Jolling Ellison Syndrome
4. Dosage: Adults, administer 10mg or 20mg once a day (refer to product manual for detailed dosage).
5. Packaging unit: 28 tablets
* Please refer to the product manual for other details, such as precautions for use.